Sample;B.cells;Macrophages.M1;Macrophages.M2;Monocytes;Neutrophils;NK.cells;T.cells.CD4;T.cells.CD8;Tregs;Dendritic.cells;Other;title;geo_accession;status;submission_date;last_update_date;type;channel_count;source_name_ch1;organism_ch1;characteristics_ch1;characteristics_ch1.1;characteristics_ch1.2;molecule_ch1;extract_protocol_ch1;extract_protocol_ch1.1;taxid_ch1;data_processing;data_processing.1;data_processing.2;data_processing.3;data_processing.4;data_processing.5;data_processing.6;data_processing.7;data_processing.8;data_processing.9;data_processing.10;platform_id;contact_name;contact_email;contact_laboratory;contact_department;contact_institute;contact_address;contact_city;contact_state;contact_zip/postal_code;contact_country;data_row_count;instrument_model;library_selection;library_source;library_strategy;relation;relation.1;supplementary_file_1;response:ch1;tissue:ch1;visit (pre or on treatment):ch1
Pt1_Pre_AD101148-6;0,080554734;0,085771393;0,105155573;0;0,151088561;0;0,461247788;0,024231328;0,091950624;0;0;Pt1_Pre_AD101148-6;GSM2420259;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124981;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405808;NONE;PD;melanoma;Pre
Pt1_On_AD174047-6;0,058199275;0,035228455;0,038311954;0;0,104325016;0;0,426793208;0,002878588;0,105043433;0,015627817;0,213592254;Pt1_On_AD174047-6;GSM2420260;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125034;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405809;NONE;PD;melanoma;On
Pt10_Pre_E9047565-6;0,023709656;0,004543198;0,038249258;0,013857938;0,053300609;0,031436682;0;0;0,013100326;0,070708204;0,751094128;Pt10_Pre_E9047565-6;GSM2420333;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125066;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405882;NONE;SD;melanoma;Pre
Pt10_On_E9047632-6;0,016695201;0,05669091;0,102592075;0;0,163246876;0,023797271;0;6,73E-05;0,016424579;0,036754567;0,583731219;Pt10_On_E9047632-6;GSM2420334;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125065;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405883;NONE;SD;melanoma;On
Pt101_Pre_AD486328-5;0,545915828;0,042825749;0,10040948;0;0,002741554;0,003240346;0,132060106;0,077577639;0,095229298;0;0;Pt101_Pre_AD486328-5;GSM2420280;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125014;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405829;NONE;PRCR;melanoma;Pre
Pt101_On_AD681975-5;0,454304321;0,055565965;0,098805971;0;0;0,001683441;0,174550829;0,088418353;0,12667112;0;0;Pt101_On_AD681975-5;GSM2420281;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125013;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405830;NONE;PRCR;melanoma;On
Pt103_Pre_AE134058-2;0,013484292;0,029947229;0,168610054;0,003926115;0,022572435;0,006176015;0;0,029898188;0,021736109;0;0,703649564;Pt103_Pre_AE134058-2;GSM2420318;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125091;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405867;NONE;PD;melanoma;Pre
Pt103_On_AE134059-6;0,010756753;0,007899771;0,021685203;0,054750524;0,040782569;0,011306582;0,016001687;0,001788702;0,012679786;0,042051983;0,78029644;Pt103_On_AE134059-6;GSM2420317;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125092;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405866;NONE;PD;melanoma;On
Pt105_On_AE373241-6;0,012809613;0,062519033;0,042458328;0,003468036;0,120982005;0,013767934;0;0,10133207;0,04277812;0,016567695;0,583317166;Pt105_On_AE373241-6;GSM2420290;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125049;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405839;NONE;PRCR;melanoma;On
Pt106_Pre_AD502250-5;0,011214608;0,058022176;0,049024959;0;0,246428714;0,015877629;0;0,017498547;0,021897422;0;0,580035944;Pt106_Pre_AD502250-5;GSM2420372;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125086;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405921;NONE;PD;melanoma;Pre
Pt106_On_AD513626-6;0,006995927;0,061193254;0,024957577;0;0,234519745;0,009858171;0;0,008790071;0,015319666;0;0,638365587;Pt106_On_AD513626-6;GSM2420373;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125085;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405922;NONE;PD;melanoma;On
Pt108_On_AE373243-6;0,018624913;0,059274073;0,177358472;0;0;0,014891502;0,070544081;0,003056909;0,006794408;0,009416851;0,640038791;Pt108_On_AE373243-6;GSM2420291;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125046;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405840;NONE;SD;melanoma;On
Pt109_On_AE527955-5;0,012541631;0,067285885;0,096241372;0,059373776;0;0,012368165;0;0,057144058;0,017985475;0;0,677059638;Pt109_On_AE527955-5;GSM2420320;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125079;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405869;NONE;PD;melanoma;On
Pt109_On_AE527955-6;0,014255892;0,056060823;0,077981765;0,061334324;0;0,015068316;0;0,036975346;0,017159119;0;0,721164414;Pt109_On_AE527955-6;GSM2420319;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125080;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405868;NONE;PD;melanoma;On
Pt11_Pre_AD153352-6;0,013786627;0,05367967;0,129098866;0,161183724;0,035194237;0,033572092;0;0,058465789;0,063350081;0;0,451668916;Pt11_Pre_AD153352-6;GSM2420362;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124987;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405911;NONE;PD;melanoma;Pre
Pt11_On_AD314068-6;0,017837796;0,066553154;0,114609855;0,138251636;0,025639031;0,032778291;0,003504545;0,046439651;0,076454849;0;0,477931193;Pt11_On_AD314068-6;GSM2420363;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124986;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405912;NONE;PD;melanoma;On
Pt13_On_AD314067-6;0,030203266;0,118372414;0,10770591;0,22361399;0;0,033119059;0;0,130651002;0,050839485;0;0,305494874;Pt13_On_AD314067-6;GSM2420364;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124985;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405913;NONE;PD;melanoma;On
Pt16_On_AD167378-6;0,010827234;0,028277722;0,018488824;0,109770619;0;0,04688736;0,0025453;0;0,01038048;0,01440269;0,75841977;Pt16_On_AD167378-6;GSM2420365;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: UNK;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124984;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405914;NONE;UNK;melanoma;On
Pt17_Pre_E9047563-6;0,003643325;0;0,189069201;0;0,029142675;0,010343276;0;0;0,006607081;0;0,761194443;Pt17_Pre_E9047563-6;GSM2420336;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125063;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405885;NONE;PD;melanoma;Pre
Pt17_On_E9261162-5;0,00390392;0;0,207519016;0;0,027484677;0,010728558;0;0;0,008598755;0;0,741765074;Pt17_On_E9261162-5;GSM2420335;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125064;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405884;NONE;PD;melanoma;On
Pt18_Pre_E9024732-6;0,194971036;0,106382738;0,14713686;0,060119531;0,032361613;0,032575981;0,132747574;0,049697828;0,064946267;0;0,179060571;Pt18_Pre_E9024732-6;GSM2420337;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125062;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405886;NONE;PRCR;melanoma;Pre
Pt18_On_E9261163-5;0,477372262;0,050390865;0,136625932;0;0;0,010771533;0;0,177725263;0,119507809;0,027606336;0;Pt18_On_E9261163-5;GSM2420338;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125061;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405887;NONE;PRCR;melanoma;On
Pt2_Pre_AD101150-6;0,0045997;0,189743247;0,228843844;0,141956444;0;0,008437991;0;0,040067188;0,057229876;0;0,329121711;Pt2_Pre_AD101150-6;GSM2420261;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125033;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405810;NONE;SD;melanoma;Pre
Pt2_On_AD174046-6;0,003095746;0,214703561;0,123260135;0,12139065;0;0,013501777;0;0,034305862;0,047936282;0;0,441805985;Pt2_On_AD174046-6;GSM2420262;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125032;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405811;NONE;SD;melanoma;On
Pt23_Pre_AD313075-5;0,016114359;0,122995494;0,149568696;0,072176029;0,04379066;0,021243984;0;0,03980793;0,040807541;0;0,493495308;Pt23_Pre_AD313075-5;GSM2420264;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: UNK;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125030;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405813;NONE;UNK;melanoma;Pre
Pt23_On_AD486568-8;0,007000482;0,110477116;0,044963047;0,10848715;0;0,014903138;0,044349367;0,077091832;0,043773865;0,046999045;0,501954958;Pt23_On_AD486568-8;GSM2420263;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: UNK;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125031;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405812;NONE;UNK;melanoma;On
Pt24_Pre_AD436687-5;0,024018564;0,206552178;0,320750914;0;0,013895607;0,005581326;0,01344112;0,021842168;0,011716716;0,035073209;0,347128198;Pt24_Pre_AD436687-5;GSM2420352;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124997;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405901;NONE;PD;melanoma;Pre
Pt26_Pre_AD467789-6;0,02046218;0,015903784;0,024607415;0;0,095525374;0,026533041;0,134323412;0,003429689;0,024473295;0,081440267;0,573301543;Pt26_Pre_AD467789-6;GSM2420366;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124983;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405915;NONE;SD;melanoma;Pre
Pt26_On_AD467915-5;0,021862561;0,019513413;0,015859304;0;0,084690072;0,01716982;0,111676062;0,000517447;0,017378287;0,061240754;0,65009228;Pt26_On_AD467915-5;GSM2420367;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124982;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405916;NONE;SD;melanoma;On
Pt27_Pre_AD453873-5;0,019574949;0,029617835;0,037965599;0;0,075646158;0,007412064;0;0,006433626;0,101223772;0,052611996;0,669514;Pt27_Pre_AD453873-5;GSM2420354;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124993;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405903;NONE;PD;melanoma;Pre
Pt27_On_AD467934-5;0,017516972;0,066697819;0,082427646;0;0,058379773;0,009715239;0;0,006845254;0,125585003;0,024944972;0,607887321;Pt27_On_AD467934-5;GSM2420353;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124996;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405902;NONE;PD;melanoma;On
Pt28_Pre_AD297619-6;0,018198639;0,005714327;0,049445398;0,08834292;0;0,033872273;0,02993183;0,015210941;0,023194146;0,04725534;0,688834187;Pt28_Pre_AD297619-6;GSM2420368;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125090;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405917;NONE;PD;melanoma;Pre
Pt28_On_AD167375-7;0,019417412;0,06398059;0,075046631;0,062227655;0,023196584;0,023125214;0,001294684;0,129188145;0,04376639;0,012732686;0,546024008;Pt28_On_AD167375-7;GSM2420369;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125089;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405918;NONE;PD;melanoma;On
Pt29_Pre_AD497504-5;0,018957526;0,108879714;0,112765888;0,086310218;0;0,059120296;0,077731067;0,004178534;0,031336505;0,029566385;0,471153867;Pt29_Pre_AD497504-5;GSM2420355;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124992;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405904;NONE;PD;melanoma;Pre
Pt3_Pre_E9024733-3;0,004889645;0,045800226;0,018891745;0;0,141145295;0,013132875;0,022537236;0;0,013390436;0,022354468;0,717858074;Pt3_Pre_E9024733-3;GSM2420324;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125075;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405873;NONE;PRCR;melanoma;Pre
Pt3_On_E9047638-6;0,019166378;0,087577401;0,03485912;0;0,12196028;0,010648456;0,019258372;0,01282561;0,028907291;0,000819794;0,663977299;Pt3_On_E9047638-6;GSM2420323;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125076;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405872;NONE;PRCR;melanoma;On
Pt30_Pre_AD497503-5;0,015885459;0,011865898;0,016836688;0,08660999;0;0,029586083;0;0,003723842;0,018398092;0,021353243;0,795740705;Pt30_Pre_AD497503-5;GSM2420357;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124994;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405906;NONE;PRCR;melanoma;Pre
Pt30_On_AD505620-6;0,020191401;0,19305768;0,507530203;0;0;0;0;0,221240744;0,050802765;0,007177207;2,22E-16;Pt30_On_AD505620-6;GSM2420356;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124995;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405905;NONE;PRCR;melanoma;On
Pt31_Pre_AD453872-5;0,018752428;0,068503691;0,096689329;0,097029119;0;0,04032075;0,031131497;0,026760964;0,057673899;0,030121441;0,533016882;Pt31_Pre_AD453872-5;GSM2420359;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124990;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405908;NONE;PD;melanoma;Pre
Pt31_On_AD467932-6;0,023961483;0,187321144;0,195558313;0,103442249;0,002006025;0,024750524;0;0,072617964;0,112391325;0;0,277950974;Pt31_On_AD467932-6;GSM2420358;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124991;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405907;NONE;PD;melanoma;On
Pt32_On_E9414883-5;0;0,083047871;0;0;0,916952129;0;0;0;0;0;0;Pt32_On_E9414883-5;GSM2420339;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125060;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405888;NONE;PD;melanoma;On
Pt34_Pre_AD466985-6;0,021113112;0,210732208;0,449004337;0;0;0;0,029823819;0,116914508;0,034093575;0;0,138318441;Pt34_Pre_AD466985-6;GSM2420375;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125083;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405924;NONE;PRCR;melanoma;Pre
Pt34_On_AD485757-6;0,009181075;0,164304479;0,520487567;0,021841627;0;0;0;0,136928789;0,005861337;0,000163198;0,141231927;Pt34_On_AD485757-6;GSM2420374;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125084;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405923;NONE;PRCR;melanoma;On
Pt35_On_AD485758-6;0,015396397;0,12800078;0,123538154;0,100552616;0;0;0;0,158357341;0,057368265;0;0,416786448;Pt35_On_AD485758-6;GSM2420376;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125082;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405925;NONE;PRCR;melanoma;On
Pt36_Pre_AD467095-6;0,005245635;0,107265616;0,231311114;0;0,23653009;0,015418829;0;0;0,007424147;0,013993015;0,382811552;Pt36_Pre_AD467095-6;GSM2420344;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125055;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405893;NONE;SD;melanoma;Pre
Pt36_On_AD495182-6;0,024206421;0,32832234;0,065884385;0;0;0,021335179;0;0,031593378;0,091169086;0,024935187;0,412554024;Pt36_On_AD495182-6;GSM2420345;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125054;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405894;NONE;SD;melanoma;On
Pt37_Pre_AD502452-5;0,016263808;0,018657572;0,016150863;0,152776334;0;0,029348927;0,046335068;0,002421805;0,024213908;0;0,693831714;Pt37_Pre_AD502452-5;GSM2420346;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125053;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405895;NONE;SD;melanoma;Pre
Pt37_On_AD495183-5;0,003824747;0,0405171;0,024914065;0,039395244;0,083376883;0,006237664;0,038992217;0,002590929;0,025804125;0;0,734347026;Pt37_On_AD495183-5;GSM2420349;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125000;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405898;NONE;SD;melanoma;On
Pt38_Pre_E9200719-6;0;0,023499233;0,02846259;0,207601232;0;0,105250955;0,105266239;0;0,044886957;0,065656294;0,4193765;Pt38_Pre_E9200719-6;GSM2420341;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125058;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405890;NONE;SD;melanoma;Pre
Pt38_On_E9414881-5;0,00025967;0,026909209;0,034833731;0,288029937;0;0,108230538;0,083879526;0;0,045259295;0,037464446;0,375133648;Pt38_On_E9414881-5;GSM2420340;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125059;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405889;NONE;SD;melanoma;On
Pt39_Pre_AD485899-5;0,017142208;0;0,001384548;0,069190209;0;0,052015906;0,019018984;0;0,017917292;0,086921628;0,736409226;Pt39_Pre_AD485899-5;GSM2420265;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125029;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405814;NONE;PD;melanoma;Pre
Pt4_Pre_E9021023-6;0,02196108;0,041509922;0,019147574;0,137479599;0;0,035627907;0,007495827;0,026190756;0,026497289;0,000364218;0,683725827;Pt4_Pre_E9021023-6;GSM2420326;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125073;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405875;NONE;SD;melanoma;Pre
Pt4_On_E9047643-7;0,038677941;0,120789019;0,115914722;0,056265659;0;0,014213181;0;0,27545637;0,088526485;0,023506092;0,266650531;Pt4_On_E9047643-7;GSM2420325;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125074;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405874;NONE;SD;melanoma;On
Pt44_Pre_AD467790-6;0,0243401;0,099775034;0,153662758;0;0,01806962;0,029477032;0;0,058835692;0,050619722;0,047605635;0,517614406;Pt44_Pre_AD467790-6;GSM2420370;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125088;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405919;NONE;PRCR;melanoma;Pre
Pt44_On_AD167376-6;0,00928859;0,030085324;0,159248802;0;0,108423067;0,021781846;0,025838781;0,068488483;0,025606867;0,016671744;0,534566496;Pt44_On_AD167376-6;GSM2420371;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125087;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405920;NONE;PRCR;melanoma;On
Pt46_Pre_AD467096-6;0,005957279;0,110051174;0,447800499;0;0,030416082;0,0010377;0,022426928;0,016797304;0,020379476;0;0,34513356;Pt46_Pre_AD467096-6;GSM2420350;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124999;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405899;NONE;PD;melanoma;Pre
Pt46_On_AD781834-6;0;0,146774657;0,435199666;0;0,03459896;0;0,017435749;0,019146655;0,015597336;0;0,331246977;Pt46_On_AD781834-6;GSM2420351;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124998;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405900;NONE;PD;melanoma;On
Pt47_Pre_AD506073-6;0,007601992;0,175774116;0,108648348;0,123534195;0,003165008;0,039324319;0,029774783;0,005451124;0,060121456;0;0,44660466;Pt47_Pre_AD506073-6;GSM2420282;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125012;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405831;NONE;PD;melanoma;Pre
Pt47_On_AD530367-6;0,00695151;0,192699321;0,06918984;0,125378888;0,003447578;0,037011902;0,035919872;0,010275392;0,055641805;0;0,463483893;Pt47_On_AD530367-6;GSM2420283;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125011;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405832;NONE;PD;melanoma;On
Pt48_Pre_E9047561-7;0,013772729;0,051259861;0,049944148;0;0,074775244;0,024842361;0;0,003820493;0,000876939;0;0,780708225;Pt48_Pre_E9047561-7;GSM2420343;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125056;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405892;NONE;PRCR;melanoma;Pre
Pt48_On_E9047631-6;0,008749056;0,047189442;0,02925063;0;0,082724594;0,02721583;0;0;0;0;0,804870448;Pt48_On_E9047631-6;GSM2420342;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125057;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405891;NONE;PRCR;melanoma;On
Pt49_Pre_AD667851-6;0,019873155;0,05231663;0,078791286;0;0,2950895;0,011639838;0,013726542;0,048155156;0,037428334;0;0,442979558;Pt49_Pre_AD667851-6;GSM2420270;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125024;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405819;NONE;PRCR;melanoma;Pre
Pt49_On_AD681976-5;0,019382474;0,23790727;0,188388433;0;0,113316073;0,002609334;0;0,279513156;0,066169222;0;0,092714038;Pt49_On_AD681976-5;GSM2420271;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125023;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405820;NONE;PRCR;melanoma;On
Pt5_Pre_E9021022-6;0,02371984;0,052482828;0,062394522;0,031605537;0,079252607;0,01170982;0,116314305;0,044494876;0,02479988;0;0,553225785;Pt5_Pre_E9021022-6;GSM2420329;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125070;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405878;NONE;PD;melanoma;Pre
Pt5_On_E9047635-6;0,018766709;0,050140635;0,050744105;0;0,177873837;0,004481505;0,087044225;0,022068387;0,012309344;0;0,576571254;Pt5_On_E9047635-6;GSM2420328;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125071;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405877;NONE;PD;melanoma;On
Pt52_Pre_AD506075-6;0,009124431;0,037548202;0,068033971;0,081587778;0,042312644;0,037413949;0;0,000891444;0,019895577;0;0,703192004;Pt52_Pre_AD506075-6;GSM2420285;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125009;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405834;NONE;PD;melanoma;Pre
Pt52_On_AD530365-6;0,007994978;0,069844983;0,069852662;0,152341587;0;0,041241236;0;0,004787482;0,026289381;0;0,62764769;Pt52_On_AD530365-6;GSM2420284;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125010;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405833;NONE;PD;melanoma;On
Pt58_On_AE045812-10;0,026821268;0,123538974;0,045491726;0,078664772;0;0,044502433;0;0,099058152;0,074773783;0,028857992;0,478290901;Pt58_On_AE045812-10;GSM2420266;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125028;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405815;NONE;SD;melanoma;On
Pt59_Pre_AD823915-5;0,017862919;0,112900522;0,151943059;0,063816551;0,002364834;0,0175632;0,022342295;0,061373718;0,050425248;0,015344626;0,484063029;Pt59_Pre_AD823915-5;GSM2420267;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125027;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405816;NONE;SD;melanoma;Pre
Pt62_Pre_AD608303-5;0,001280228;0;0,006419375;0;0,188529723;0,004782792;0,000135377;0,001033604;0,001194128;0;0,796624774;Pt62_Pre_AD608303-5;GSM2420302;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125037;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405851;NONE;PD;melanoma;Pre
Pt62_On_AD635728-5;0,002938471;0;0,005711552;0;0,33741879;0,005042561;0;0,000179748;0,001625538;0;0,647083339;Pt62_On_AD635728-5;GSM2420301;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125038;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405850;NONE;PD;melanoma;On
Pt65_Pre_AD793919-6;0,014189679;0,032416944;0,045563128;0,00465989;0,128571352;0,010533479;0,027094065;0,021924671;0,026492795;0,046606097;0,641947899;Pt65_Pre_AD793919-6;GSM2420303;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125036;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405852;NONE;SD;melanoma;Pre
Pt65_On_AD796996-5;0,013375746;0,045778639;0,03938926;0,025061923;0,17165801;0,009075516;0,018797239;0,028128403;0,033745509;0,008683192;0,606306563;Pt65_On_AD796996-5;GSM2420304;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125035;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405853;NONE;SD;melanoma;On
Pt66_Pre_AD667850-6;0,007632496;0,031760002;0,024735785;0,173414634;0;0,069683763;0,07527475;0,001009084;0,020849487;0,018670852;0,576969148;Pt66_Pre_AD667850-6;GSM2420272;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125022;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405821;NONE;PD;melanoma;Pre
Pt67_Pre_AD506074-6;0,0191504;0,012106952;0,021511228;0;0,059981933;0,006599613;0;0,009992711;0,004909061;0;0,865748102;Pt67_Pre_AD506074-6;GSM2420286;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125008;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405835;NONE;SD;melanoma;Pre
Pt67_On_AD530366-6;0,015370334;0,008472882;0,017813866;0;0,041685601;0,007441047;0;0,008402162;0,004685278;0;0,896128831;Pt67_On_AD530366-6;GSM2420287;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125007;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405836;NONE;SD;melanoma;On
Pt68_On_AD635729-6;0,023555718;0,043940852;0,042904024;0,070244447;0,080961301;0,01683732;0,11551055;0;0,016188235;0;0,589857554;Pt68_On_AD635729-6;GSM2420305;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125104;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405854;NONE;PRCR;melanoma;On
Pt69_On_AD635730-6;0,028151217;0,18358087;0,423117923;0;0;0;0;0,156631529;0,01867653;0;0,18984193;Pt69_On_AD635730-6;GSM2420306;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125103;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405855;NONE;PRCR;melanoma;On
Pt72_Pre_AD793922-5;0,015169375;0,089195163;0,017679551;0,167862631;0;0,0448871;0;0;0,021076682;0;0,644129499;Pt72_Pre_AD793922-5;GSM2420307;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125102;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405856;NONE;PRCR;melanoma;Pre
Pt76_Pre_AD667852-6;0;0,049683971;0;0,009635734;0,058030245;0,018486895;0,009318654;0,000406144;0,012440453;0,001425073;0,840572832;Pt76_Pre_AD667852-6;GSM2420273;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: UNK;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125021;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405822;NONE;UNK;melanoma;Pre
Pt77_Pre_AD733591-7;0,134181247;0,065683769;0,098773735;0,006911237;0,018621313;0,009865096;0,034641186;0,085750121;0,109945272;0,009241328;0,426385695;Pt77_Pre_AD733591-7;GSM2420292;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125045;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405841;NONE;SD;melanoma;Pre
Pt77_On_AD733629-8;0,27902963;0,02892701;0,128209573;0;0,003282425;0,010887297;0,177117013;0,11561408;0,138862349;0,034046907;0,084023715;Pt77_On_AD733629-8;GSM2420293;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125044;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405842;NONE;SD;melanoma;On
Pt78_Pre_AD467018-5;0,003770271;0;0,007090715;0,078358922;0;0,033407248;0,034984003;0;0,012826614;0,016021824;0,813540402;Pt78_Pre_AD467018-5;GSM2420310;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125099;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405859;NONE;PD;melanoma;Pre
Pt78_On_AE148748-6;0,006301384;0,010096119;0,05355619;0;0,182760329;0,03098284;0,015664218;0,004523892;0,015778137;0,034189744;0,646147147;Pt78_On_AE148748-6;GSM2420308;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125101;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405857;NONE;PD;melanoma;On
Pt79_Pre_AD733587-5;0,015361257;0,024588063;0,024693347;0,062466861;0,070783313;0,040820545;0,045669872;0,007001697;0,027804066;0,017080855;0,663730122;Pt79_Pre_AD733587-5;GSM2420295;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125042;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405844;NONE;SD;melanoma;Pre
Pt79_On_AD733628-6;0,016447983;0,032057117;0,044238388;0,059043596;0,037107234;0,038387747;0,041381145;0,016441759;0,033416319;0,015972593;0,665506118;Pt79_On_AD733628-6;GSM2420294;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125043;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405843;NONE;SD;melanoma;On
Pt8_Pre_AD153354-6;0,016747845;0,060149973;0,088677096;0,149723508;0;0,039257045;0,004258698;0,024733585;0,03322826;0;0,583223989;Pt8_Pre_AD153354-6;GSM2420360;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124989;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405909;NONE;PD;melanoma;Pre
Pt8_On_AD167380-7;0,008170258;0,09699778;0,049814456;0,134100458;0;0,040652606;0,00308405;0,025874623;0,026728856;0;0,614576913;Pt8_On_AD167380-7;GSM2420361;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06124988;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405910;NONE;PD;melanoma;On
Pt80_On_AD467874-5;0,013942658;0,075635947;0,142275937;0,131140092;0;0,022152749;0;0,079769943;0,039618211;0;0,495464465;Pt80_On_AD467874-5;GSM2420311;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125098;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405860;NONE;PD;melanoma;On
Pt81_On_AD681973-5;0,027749881;0,129478395;0,109801814;0,087471296;0;0,009000013;0;0,161478605;0,074183106;0;0,400836891;Pt81_On_AD681973-5;GSM2420274;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125020;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405823;NONE;PD;melanoma;On
Pt82_Pre_AD823914-8;0,014545479;0,034602354;0,139558899;0;0;0,014313027;0;0,022518168;0,02378134;0,038132702;0,712548032;Pt82_Pre_AD823914-8;GSM2420268;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125026;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405817;NONE;SD;melanoma;Pre
Pt82_On_AD125218-6;0,015373054;0,046855917;0,079814153;0;0,057269798;0,019281831;0;0,04396086;0,031567846;0,011728423;0,694148118;Pt82_On_AD125218-6;GSM2420269;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125025;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405818;NONE;SD;melanoma;On
Pt84_Pre_AD486532-5;0,015095115;0,006585884;0,073248089;0,008767715;0,012002479;0,015102659;0,005647517;0;0;0;0,863550542;Pt84_Pre_AD486532-5;GSM2420296;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125048;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405845;NONE;PD;melanoma;Pre
Pt84_On_AD495199-6;0,014115286;0,006725423;0,074805429;0;0,009901315;0,013161094;0,010731206;0;0,001185692;0,003444981;0,865929573;Pt84_On_AD495199-6;GSM2420297;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125047;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405846;NONE;PD;melanoma;On
Pt85_Pre_AD486329-5;0,020806405;0,011712657;0,024122227;0,114144401;0;0,04245077;0,049483781;0;0,017737939;0,015399929;0,704141891;Pt85_Pre_AD486329-5;GSM2420275;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125019;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405824;NONE;PD;melanoma;Pre
Pt85_On_AE070989-10;0,025799948;0,01843194;0,031577806;0,14645369;0;0,043528084;0,040574299;0;0,02284324;0,006131566;0,664659428;Pt85_On_AE070989-10;GSM2420276;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125018;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405825;NONE;PD;melanoma;On
Pt87_On_AD495198-6;0,061448709;0,281752723;0,213994104;0;0;0,021403376;0;0,289935765;0,087725622;0,043739701;0;Pt87_On_AD495198-6;GSM2420298;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125041;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405847;NONE;SD;melanoma;On
Pt89_Pre_AE070951-5;0,004869166;0,074069194;0,050429513;0,084603346;0,066266146;0,035847964;0,035083998;0,003090372;0,033169495;0;0,612570806;Pt89_Pre_AE070951-5;GSM2420277;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125017;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405826;NONE;SD;melanoma;Pre
Pt89_On_AE070987-5;0;0,12805364;0,054904132;0,167857198;0,017056619;0,062612023;0,089897381;0,016855692;0,060136465;0;0,402626851;Pt89_On_AE070987-5;GSM2420278;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125016;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405827;NONE;SD;melanoma;On
Pt9_Pre_E9021024-6;0,008135335;0,042693546;0,094189518;0,068953097;0;0,05797285;0,063888481;0,009123489;0,020533351;0,202158327;0,432352005;Pt9_Pre_E9021024-6;GSM2420331;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125068;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405880;NONE;PD;melanoma;Pre
Pt9_On_E9047644-7;0,015199246;0,01901934;0,062812542;0,164267357;0;0,066167442;0,026021034;0,00752266;0,030238776;0,114084996;0,494666606;Pt9_On_E9047644-7;GSM2420332;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125067;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405881;NONE;PD;melanoma;On
Pt90_Pre_AD467873-6;0,006585776;0,073838206;0,041833098;0;0,171819118;0,010644642;0;0,024427957;0,021712444;0;0,64913876;Pt90_Pre_AD467873-6;GSM2420312;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125097;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405861;NONE;PD;melanoma;Pre
Pt92_Pre_AE134060-5;0,02005513;0,079275674;0,086459154;0,133290862;0;0,027165434;0,026132207;0,089969249;0,041548402;0,002228648;0,49387524;Pt92_Pre_AE134060-5;GSM2420313;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125096;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405862;NONE;SD;melanoma;Pre
Pt92_On_AE148750-5;0,029022598;0,11015796;0,09828614;0,085475566;0;0,007247759;0;0,396250687;0,097687593;0,015970137;0,15990156;Pt92_On_AE148750-5;GSM2420316;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125093;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405865;NONE;SD;melanoma;On
Pt93_On_AE070988-5;0,015835438;0,029563077;0,029100182;0;0,171909663;0,013614877;0;0;0,025063153;0,018565259;0,696348351;Pt93_On_AE070988-5;GSM2420279;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125015;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405828;NONE;PD;melanoma;On
Pt94_Pre_AD732850-6;0,017784087;0,007765027;0,069955904;0;0,018918944;0,009626377;0;0,012073534;0,081538674;0,054251227;0,728086227;Pt94_Pre_AD732850-6;GSM2420289;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125050;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405838;NONE;PRCR;melanoma;Pre
Pt94_On_AE373242-6;0,006773896;0,027847783;0,049781671;0;0,086858059;0,019992518;0;0,008273117;0,023504236;0,014141196;0,762827526;Pt94_On_AE373242-6;GSM2420288;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: PRCR;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125006;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405837;NONE;PRCR;melanoma;On
Pt98_Pre_AD733586-8;0,008656074;0,003110905;0,03638393;0;0,097608443;0,006448715;0;0,000524706;0,002144022;0,006218746;0,838904459;Pt98_Pre_AD733586-8;GSM2420299;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): Pre;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125040;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405848;NONE;SD;melanoma;Pre
Pt98_On_AE086717-6;0,016305361;0,030035211;0,097437425;0;0,093902422;0,007230188;0;0,027959572;0,022209408;0,012546823;0,69237359;Pt98_On_AE086717-6;GSM2420300;Public on Jan 23 2018;Dec 08 2016;May 15 2019;SRA;1;tumor;Homo sapiens;visit (pre or on treatment): On;response: SD;tissue: melanoma;total RNA;RNA Later;RNASeq;9606;Raw reads in the fastq format were aligned to Human Genome HG19 using the RNAseq STAR aligner version 2.4.0d.;Mapped reads for each sample were counted for each gene in annotation files TxDb.Hsapiens.UCSC.hg19.knownGene using the  GenomicFeatures read summarization program;Raw reads were normalized with regularized-logarithm transformation (rlog function with robust estimation);Normalized FPKM (fragments per kilobase per million mapped reads) were obtained using the robust fpkm estimate function of DeSeq2 v1.12.4.;To refine subsets of immune cells that were present in each sample, cibersort was used to conduct immune de-convolution on the FPKM values of each patient;Genome_build: HG19;Gene IDs in the processed data files are NCBI Entrez Gene IDs.;Supplementary_files_format_and_content: Row and normalized feature count matrices;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.raw.csv.gz: Raw feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.rld.csv.gz: Rlog-transformed values feature counts matrix;Supplementary_files_format_and_content: BMS038_118Sample.hg19KnownGene.fpkm.csv.gz: Normalized FPKM feature counts matrix;GPL9052;Vladimir,,Makarov;makarov@ccf.org;CITI;LRI;Cleveland Clinic;9500 Euclid Ave;Cleveland;OH;44195;USA;0;Illumina Genome Analyzer;cDNA;transcriptomic;RNA-Seq;BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN06125039;SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX2405849;NONE;SD;melanoma;On